Oral semaglutide is well established. Oral tirzepatide is a much thinner market, and the difference in availability shows up directly in the price.
Key Takeaways
- Sublingual is the dominant compounded oral tirzepatide format.
- Published oral tirzepatide pricing sits well above oral semaglutide across the market.
- There is no approved oral tirzepatide product, so every oral tirzepatide preparation is compounded.
- Bioavailability data for compounded oral tirzepatide is not generally published.
- Verify concentration, format and beyond-use dating before ordering, because standardization does not exist.
| Attribute | Oral semaglutide | Oral tirzepatide |
|---|---|---|
| Approved product exists | Yes | No |
| Common compounded format | Sublingual, drops, tablets | Sublingual |
| Typical published price | From about $99/mo | From about $229/mo |
| Market availability | Widely offered | Offered by a smaller set of providers |
| Published bioavailability data | For the approved product only | Not generally available |
Why oral tirzepatide is scarcer
There is no approved oral tirzepatide product. Where oral semaglutide has an approved reference product that demonstrated oral delivery is achievable for that molecule, oral tirzepatide has no such precedent.
Everything offered as oral tirzepatide is therefore a compounded preparation, and the compounders offering it are a smaller group than those offering oral semaglutide. Thinner supply plus higher input cost produces the price gap you see.
MadeMed — Oral Tirzepatide
Sublingual- Sublingual tirzepatide is still relatively rare — most oral compounding is semaglutide
- Quarterly billing available
- Dose tiers are priced separately; confirm your tier at checkout
Compounded medications are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed. Compounded GLP-1 medications are prepared by state-licensed pharmacies and are not the same as FDA-approved brand products.
What the higher price buys, and what it does not
Tirzepatide's clinical trial programme reported larger mean weight reduction than semaglutide's, which is the reason for the demand. That evidence comes from injectable tirzepatide at studied doses.
Extending it to a compounded sublingual preparation involves two assumptions: that the oral route delivers a comparable systemic exposure, and that the compounded formulation performs as the preparation used in trials did. Neither has published data behind it.
This is not an argument that oral tirzepatide does not work. It is an argument for calibrating your expectations to the evidence that actually exists rather than to the injectable trial results.
Telos Rx
Flat pricing by plan length- Pricing is flat across dose tiers once your plan length is set
- 12-month plan carries the lowest monthly rate
- Cancel anytime; FSA/HSA accepted
Telos prices by commitment length rather than by milligram, which changes how you should compare it against dose-tiered competitors.
Compounded medications are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed. Compounded GLP-1 medications are prepared by state-licensed pharmacies and are not the same as FDA-approved brand products.
MadeMed — Oral Semaglutide
Sublingual- Sublingual format — dissolves under the tongue, no swallowing water required
- Quarterly billing available at a lower effective monthly rate
- Optional membership program discounts refills
Compounded medications are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed. Compounded GLP-1 medications are prepared by state-licensed pharmacies and are not the same as FDA-approved brand products.
What to verify before you order
- Concentration and format. What exactly is supplied, at what strength, in what container.
- The compounding pharmacy. Which facility prepares it, and whether it is a 503A pharmacy or a 503B outsourcing facility.
- Beyond-use date. When the preparation expires, and whether that changes once opened.
- Dosing instructions specific to your preparation. Not generic instructions from elsewhere.
- What happens at higher doses. Whether the price tiers upward as you escalate.
A provider that answers all five plainly is giving you the information you need. One that deflects on the pharmacy question in particular is worth a second thought.
Frequently Asked Questions
Is there an FDA-approved oral tirzepatide?
No. Every oral tirzepatide preparation available is compounded, and compounded medications are not FDA-approved.
Why does oral tirzepatide cost more than oral semaglutide?
Fewer compounders offer it, input costs are higher, and there is no approved reference product creating competitive pressure.
Does oral tirzepatide work as well as the injection?
Comparative data is not published. The trial evidence for tirzepatide comes from injectable preparations at studied doses.
What format does oral tirzepatide come in?
Sublingual is the dominant format in the compounded market.